For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221202:nRSB4218Ia&default-theme=true
RNS Number : 4218I Capital Group Companies Inc 02 December 2022
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing The Capital Group Companies, Inc.
Company dealt in Sanofi
Class of relevant security to which the Ordinary Shares (FR0000120578)
dealings being disclosed relate
Date of dealing 01 December 2022
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security
dealt in
Long Short
Number (%) Number (%)
(1) Relevant securities 4,862,186 shares 0.38 %
(2) Derivatives (other than options):
(3) Options and agreements to purchase/sell:
Total 4,862,186 shares 0.38 %
(b) Interests and short positions in relevant securities of the company, other
than the
class dealt in
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options):
(3) Options and agreements to purchase/sell:
Total
3. DEALINGS
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2,387 shares 87.4607 - EUR
Purchase 67 shares 87.4800 - EUR
(b) Derivatives transactions (other than options transactions)
Product name Nature of transaction Number of relevant securities Price per unit
e.g. CFD
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which the option relates Exercise price Type, e.g. American, European etc. Expiry date Option money paid/ received per unit
(ii) Exercising
Product name Number of securities Exercise price per unit
e.g. call option
(d) Other dealings (including subscribing for new securities)
Nature of transaction Details Price per unit (if applicable)
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 attached? NO
Date of disclosure 02 December 2022
Contact name Torrence M. Frame
Telephone number 213 615 0469
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ISEMZMGZLZKGZZG